These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20002538)

  • 21. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
    Augustsson C; Hilden I; Petersen LC
    Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
    Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
    J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.
    Knappe S; Gorczyca ME; Jilma B; Derhaschnig U; Hartmann R; Palige M; Scheiflinger F; Dockal M
    Thromb Haemost; 2013 Mar; 109(3):450-7. PubMed ID: 23348798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.
    Winckers K; Siegerink B; Duckers C; Maurissen LF; Tans G; Castoldi E; Spronk HM; Ten Cate H; Algra A; Hackeng TM; Rosendaal FR
    J Thromb Haemost; 2011 Nov; 9(11):2243-50. PubMed ID: 21895962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.
    Ndonwi M; Tuley EA; Broze GJ
    Blood; 2010 Aug; 116(8):1344-51. PubMed ID: 20479289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of TFPI function by protein S.
    Hackeng TM; Maurissen LF; Castoldi E; Rosing J
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():165-8. PubMed ID: 19630792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.
    Reglińska-Matveyev N; Andersson HM; Rezende SM; Dahlbäck B; Crawley JT; Lane DA; Ahnström J
    Blood; 2014 Jun; 123(25):3979-87. PubMed ID: 24740810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency.
    Castoldi E; Maurissen LF; Tormene D; Spiezia L; Gavasso S; Radu C; Hackeng TM; Rosing J; Simioni P
    Haematologica; 2010 Sep; 95(9):1563-71. PubMed ID: 20421270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.